Mark Reilly

China’ action against British executive may prompt firms to rethink their investments

China’ action against British executive may prompt firms to rethink their investments

Chinese police's action against a British executive of GlaxoSmithKline Plc might cause some international companies to rethink their investment plans in the country.

Former GSK China head & others charged with corruption

Former GSK China head & others charged with corruption

Pharmaceuticals giant GlaxoSmithKline Plc's (GSK's) former China head Mark Reilly and two of his colleagues have been charged with corruption by Chinese police.